Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daniela Bruecher"'
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract The antiapoptotic protein BCL2A1 is highly, but very heterogeneously expressed in Diffuse Large B-cell Lymphoma (DLBCL). Particularly in the context of resistance to current therapies, BCL2A1 appears to play an important role in protecting c
Externí odkaz:
https://doaj.org/article/4e919351ac654b7faa7836358a215e7f
Autor:
Victoria M. Smith, Anna Dietz, Kristina Henz, Daniela Bruecher, Ross Jackson, Lisa Kowald, Sjoerd J.L. van Wijk, Sandrine Jayne, Salvador Macip, Simone Fulda, Martin J.S. Dyer, Meike Vogler
Publikováno v:
Haematologica, Vol 105, Iss 8 (2020)
The BCL-2-specific inhibitor, ABT-199 (venetoclax) has exhibited remarkable clinical activity in nearly all cases of chronic lymphocytic leukemia. In contrast, responses are usually much less in diffuse large B-cell lymphoma (DLBCL), despite high lev
Externí odkaz:
https://doaj.org/article/319ce7a40074445598d5e3c9e2f33b2f
Autor:
Simone Fulda, Anna Dietz, Sandrine Jayne, Victoria M. Smith, Martin J. S. Dyer, Salvador Macip, Meike Vogler, Kristina Henz, Ross Jackson, Daniela Bruecher, Lisa Kowald, Sjoerd J L van Wijk
Publikováno v:
Haematologica. 105:2150-2163
The BCL-2-specific inhibitor, ABT-199 (venetoclax) has exhibited remarkable clinical activity in nearly all cases of chronic lymphocytic leukemia. In contrast, responses are usually much less in diffuse large B-cell lymphoma (DLBCL), despite high lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f25d70e47fdc9e2783e6f7221975702
https://doi.org/10.3324/haematol.2019.220525
https://doi.org/10.3324/haematol.2019.220525